Orthofix International N.V.

Orthofix International N.V.

Orthofix International N.V. was established as a Netherlands-based entity, though its operational headquarters are in Edison, New Jersey. The company was formed through the merger of Orthofix and SeaSpine in 2021, creating a combined entity with a broader product portfolio across spinal implants, biologics, and orthopedic fixation devices. The wealth origin of the company traces to its legacy as a publicly traded firm, not a family-owned enterprise. The company's strategy centers on developing and marketing medical devices for the spine and orthopedic markets. Its Spine segment includes interbody fusion devices, pedicle screw systems, and cervical plates, while the Orthopedics segment covers external fixators and bone growth stimulators. Key competitors include NuVasive, Medtronic, and Stryker. Geographically, Orthofix sells in the Americas, Europe, the Middle East, and Asia-Pacific. Orthofix employs approximately 1,100 people, with additional offices in Los Angeles and locations in Europe and Latin America. The company does not operate a separate philanthropic foundation; any charitable activities are managed through corporate giving. As of May 2025, the firm announced plans to spin off its biologics business into a separate company named Orthofix Biologics, pending regulatory approvals (per Orthofix press release, May 2025). What distinguishes Orthofix from pure-play medical-device firms is its Netherlands-based corporate structure, which provides a dual regulatory framework for US and European markets. This allows tailored product approvals and liability strategies across jurisdictions, a structural differentiator in the highly regulated medtech space.